homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

July 29, 2002

Genemax

Genemax Corp., as part of restructuring following the reverse takeover of GeneMax Pharmaceuticals, named Dr. Julia Levy chairman of the board of directors. Levy is joined by Ron Handford, Dr. Wilf Jefferies, James Davidson, Dr. Calvin Stiller, Alan Linday, and Grant Atkins as directors. Handford will serve as president and CEO, Davidson will serve as chief financial officer and secretary, and Jefferies will serve as chief scientist officer. GeneMax, based in Blaine, is a biotech company specializing in the treatment of cancer, and therapies for infectious diseases, autoimmune disorders and transplant tissue rejection.




Email or user name:
Password:
 
Forgot password? Click here.